CEO trust of Celestica (CLS) sells 18,176 shares under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Celestica Inc. reported a Form 4 showing open-market sales of common shares by a trust associated with Chief Executive Officer Robert Mionis. Mionis 2026 GRAT Number Three sold 18,176 common shares on June 17, 2026 at prices between $377.93 and $392.205 per share.
The filing notes these transactions were made under a pre-arranged Rule 10b5-1 trading plan adopted on March 11, 2026. After these transactions, the report shows Mionis with 453,697 common shares held directly and additional indirect holdings of 210,445 and 145,565 common shares in Mionis 2026 GRAT Number One and Number Two, respectively.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 18,176 shares ($7,000,835)
Net Sell
17 txns
Insider
MIONIS ROBERT
Role
Chief Executive Officer
Sold
18,176 shs ($7.00M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Shares | 341 | $378.37 | $129K |
| Sale | Common Shares | 1,515 | $379.50 | $575K |
| Sale | Common Shares | 437 | $380.25 | $166K |
| Sale | Common Shares | 760 | $381.45 | $290K |
| Sale | Common Shares | 1,520 | $382.43 | $581K |
| Sale | Common Shares | 1,721 | $383.42 | $660K |
| Sale | Common Shares | 1,850 | $384.36 | $711K |
| Sale | Common Shares | 2,440 | $385.44 | $940K |
| Sale | Common Shares | 1,431 | $386.25 | $553K |
| Sale | Common Shares | 1,510 | $387.27 | $585K |
| Sale | Common Shares | 1,560 | $388.51 | $606K |
| Sale | Common Shares | 2,352 | $389.40 | $916K |
| Sale | Common Shares | 579 | $390.18 | $226K |
| Sale | Common Shares | 160 | $392.11 | $63K |
| holding | Common Shares | -- | -- | -- |
| holding | Common Shares | -- | -- | -- |
| holding | Common Shares | -- | -- | -- |
Holdings After Transaction:
Common Shares — 78,219 shares (Indirect, By Mionis 2026 GRAT Number Three);
Common Shares — 453,697 shares (Direct, null)
Footnotes (1)
- This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 11, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $377.93-$378.83, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $379.00-$379.92, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $379.98 -$380.55, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $380.97-$381.85, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $381.99-$382.87, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $382.94-$383.91, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $383.93 -$384.89, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $384.94 -$385.90, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $385.96 -$386.83, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $386.94 -$387.64, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $387.98 -$388.92, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $388.96-$389.84, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $389.96-$390.59, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $391.95-$392.205 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Shares sold: 18,176 shares
Sale price range: $377.93–$392.205 per share
Direct holdings after: 453,697 shares
+3 more
6 metrics
Shares sold
18,176 shares
Open-market sales on June 17, 2026
Sale price range
$377.93–$392.205 per share
Prices across multiple sale tranches
Direct holdings after
453,697 shares
Common shares held directly by Robert Mionis
Mionis 2026 GRAT Number One
210,445 shares
Indirect common share holdings after transactions
Mionis 2026 GRAT Number Two
145,565 shares
Indirect common share holdings after transactions
Sell transactions count
14 transactions
Non-derivative open-market sales summarized in Form 4
Key Terms
Rule 10b5-1 plan, weighted average price, Mionis 2026 GRAT Number Three, grantor retained annuity trust (GRAT)
4 terms
Rule 10b5-1 plan financial
"This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 11, 2026."
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Mionis 2026 GRAT Number Three financial
"direct_or_indirect: I, nature_of_ownership: By Mionis 2026 GRAT Number Three"
grantor retained annuity trust (GRAT) financial
"nature_of_ownership: By Mionis 2026 GRAT Number One/Two/Three"
FAQ
What insider transaction did Celestica (CLS) report for CEO Robert Mionis?
Celestica reported that a trust associated with CEO Robert Mionis sold 18,176 common shares. The sales were executed on June 17, 2026, as open-market transactions at various prices, according to a Form 4 insider trading report.